June 22, 2011

The United Kingdom's pharmacy-led health and beauty retailer Boots — whose branded products are available in the United States at Target, Target.com, ShopBootsUSA.com, Ulta stores and at Shoppers Drug Mart in Canada — has named Sandra Gabriele, VP marketing and communications for Boots Retail USA, as its International Employee of the Year, part of the retailer's annual "Best of the Best Awards."

June 22, 2011

Generic drug maker Dr. Reddy’s Labs has launched its version of a popular antibiotic.

June 22, 2011

Diabetica Research Solutions has expanded distribution of its DRSI ReStore! Energy product to Publix stores that operate in-store pharmacies.

June 22, 2011

Endo Pharmaceuticals has acquired a provider of devices and therapies for male and female pelvic health.

June 22, 2011

Genesis Today on Tuesday launched its GenEssentials Greens, a concentrated vegan supplement with more than 75 plant-based ingredients.

June 22, 2011

Impax Labs has expanded its senior management team with two appointments.

June 22, 2011

The Department of Health and Human Services’ National Diabetes Education Program has unveiled a series of videos designed to help people make lifestyle changes and cope with the demands of diabetes.

June 22, 2011

Rep. Tom Marino, R-Pa., on Monday propositioned a bill that would allow independent drug stores to band together in an effort to increase their collective pharmaceutical buying power.

June 22, 2011

Omnicare has added two members to its board of directors.

June 22, 2011

The Food and Drug Administration has approved a medication designed to treat acute and chronic moderate to severe pain, where the use of an opioid analgesic is suitable.

June 22, 2011

ProStrakan has received approval from the Food and Drug Administration to market an ointment designed to treat moderate to severe pain associated with chronic anal fissures.

June 22, 2011

A company best known for keeping credit scores on consumers is planning to rate their medication adherence as well, according to published reports.

June 22, 2011

After Walgreens made its contract dispute with Express Scripts public on Tuesday morning, the pharmacy benefit manager stated it is open to continued negotiations with Walgreens.

June 21, 2011

General Nutrition Centers announced that its president and chief merchandising officer has resigned.

June 21, 2011

Elisa Technologies recently announced that its EZ Gluten test kit has earned Performance-Tested Methods certification from the AOAC Research Institute, a private, not-for-profit association that helps establish testing standards.

June 21, 2011

The Food and Drug Administration Tuesday approved the first generic versions of an antibiotic designed to treat certain infections in people ages 18 years and older.

June 21, 2011

The Department of Health and Human Services on Tuesday morning unveiled the nine graphic health warnings mandated by the Food and Drug Administration to appear on every pack of cigarettes sold in the United States and in every cigarette advertisement.

June 21, 2011

Walgreens on Tuesday announced the company no longer will participate in the Express Scripts network beginning Jan. 1, 2012, citing unsuccessful renewal negotiations.

June 21, 2011

Soon after reporting double-digit earnings per share growth Tuesday morning, Walgreens announced it would forego as much as $5.3 billion in annual sales, representing some 7% of the company’s business and 90 million prescriptions, as it walks away from its relationship with pharmacy benefit manager Express Scripts.

June 21, 2011

Watson subsidiary Watson Labs is seeking approval for a drug designed to treat symptomatic benign prostatic hyperplasia in men with an enlarged prostate.

June 20, 2011

The Food and Drug Administration has approved a new formulation of an injectable drug made by Abbott for prostate cancer.

June 20, 2011

CVS/pharmacy has introduced its latest initiative, designed to underscore the role pharmacists play in managing ongoing medications for chronic illnesses, particularly when a patient starts a new medication.

June 20, 2011

A panel of Food and Drug Administration experts has recommended approval of an investigational biotech drug made by Regeneron Pharmaceuticals for eye diseases.

June 20, 2011

Johnson & Johnson is recalling 40,000 bottles of a drug used to treat schizophrenia due to consumer reports of the drug having a strange odor, the company said Friday.